Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
May 17 2007 - 5:05PM
PR Newswire (US)
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will webcast its Annual Meeting of Stockholders
on Wednesday, May 23, 2007 at 10:00 a.m. Pacific Time from the
company's corporate headquarters in San Diego, CA. Following the
Annual Meeting, Daniel M. Bradbury, President and Chief Executive
Officer of Amylin Pharmaceuticals, will be providing a corporate
overview. The presentation will be webcast live, and a recording
will be made available following the event. The webcast and
recording will be accessible through Amylin's corporate website,
located at http://www.amylin.com/. To access the live webcast,
please log on to Amylin's site approximately fifteen minutes prior
to the presentation to register and download any necessary audio
software. About Amylin Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is located in San Diego, California
with over 1,600 employees nationwide. Further information on Amylin
Pharmaceuticals is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive
Director, Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024